Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Frontiers in Oncology|April 2, 2019
Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative DisordersJames P Dugan, Carrie B Coleman, Bradley HaverkosJournal of Virology|October 8, 2010
Immature and transitional B cells are latency reservoirs for a gammaherpesvirusCarrie B Coleman, Michael S Nealy, Scott A TibbettsJournal of Virology|April 3, 2020
CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T CellsNicholas A Smith, Carrie B Coleman, Benjamin E Gewurz, et al.Journal of Virology|May 21, 2010
Use of a virus-encoded enzymatic marker reveals that a stable fraction of memory B cells expresses latency-associated nuclear antigen throughout chronic gammaherpesvirus infectionMichael S Nealy, Carrie B Coleman, Haiyan Li, et al.Cytometry. Part B, Clinical Cytometry|September 9, 2017
Changes in Tonsil B Cell Phenotypes and EBV Receptor Expression in Children Under 5-Years-OldEric M Wohlford, Paul C Baresel, Joel R Wilmore, et al.Journal of Virology|December 16, 2014
Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokinesCarrie B Coleman, Eric M Wohlford, Nicholas A Smith, et al.Journal of Virology|August 10, 2018
Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized MiceCarrie B Coleman, Julie Lang, Lydia A Sweet, et al.The Journal of Infectious Diseases|September 22, 2017
Epstein-Barr Virus Type 2 Infects T Cells in Healthy Kenyan ChildrenCarrie B Coleman, Ibrahim I Daud, Sidney O Ogolla, et al.Mbio|May 29, 2014
Virus-encoded microRNAs facilitate gammaherpesvirus latency and pathogenesis in vivoEmily R Feldman, Mehmet Kara, Carrie B Coleman, et al.Plos Pathogens|June 6, 2019
Multidimensional analysis of Gammaherpesvirus RNA expression reveals unexpected heterogeneity of gene expressionLauren M Oko, Abigail K Kimball, Rachael E Kaspar, et al.Pageof 2